By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Toyama Chemical Company, Ltd. 

2-5, Nishishinjuku 3-chome

Shinjuku-ku  Tokyo  160-0023  Japan
Phone: 81-3-5381-3889 Fax: 81-3-3348-6460



Company News
Eisai And Toyama Chemical Clear All-Case Surveillance Condition For Approval Of Antirheumatic Agent Iguratimod 12/1/2015 9:42:14 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Toyama Chemical NDA Approval Of “AVIGAN Tablet 200mg” In Japan For The Anti-influenza Virus Drug 10/19/2014 2:49:32 PM
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 10/10/2014 4:13:57 PM
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/10/2014 4:10:34 PM
Cempra Pharmaceuticals, Inc. Gets $10 Million Milestone Payment From Toyama Chemical Company 9/9/2014 6:22:08 AM
Cempra Pharmaceuticals, Inc., Toyama Chemical Company Ink Up to $70 Million Pact to Produce Anti-Pneumonia Drug 5/14/2013 6:39:32 AM
Eisai Company, Ltd. (ESALY.PK) and Toyama Chemical Company Receive Approval to Market Anti-rheumatic Agent Iguratimod in Japan 6/29/2012 7:11:26 AM
FUJIFILM Holdings Corporation (FUJI) Launches $1.45B bid for Toyama Chemical Company 2/13/2008 6:15:35 AM
Toyama Chemical Company Chemical Submits IND For Its Anti-Influenza Compound 'T-705' 1/25/2007 11:52:38 AM